SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN

Core Insights - Sera Prognostics Inc. announced the appointment of Jeff Elliott to its Board of Directors, effective March 20, 2025, while Ryan Trimble will retire on June 30, 2025, after 14 years with the company [1][2] - The company is focused on improving maternal and neonatal health through innovative pregnancy biomarker information, particularly with its PreTRM® test [1][4] Company Developments - Jeff Elliott brings extensive experience in corporate strategy, business operations, and commercializing molecular diagnostics, which will aid Sera in leveraging recent PRIME study results for market building [2][3] - Ryan Trimble expressed confidence in the company's direction and the successful completion of the PRIME study, indicating a strong foundation for future growth [3] Product Information - Sera Prognostics specializes in precision pregnancy care, aiming to reduce healthcare delivery costs through early prediction of preterm birth risk and other pregnancy complications [4] - The PreTRM® Test is a validated blood-based biomarker test that predicts the risk of spontaneous preterm birth, allowing for personalized clinical decisions [7]